Sign in

CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company

Entera Bio Ltd.

Sign in to watch
Ticker
ENTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972-2-532-7151
Business address
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Regulation FD disclosure
  3. 10-K/A Report 10-K/A
  4. 4 Derivatives Options or other derivatives
  5. 10-K Report Annual Report
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy Director bought 10,000 shares at $2.74 ($27,378)
  10. 4 Open-market buy U.S.based CFO bought 10,000 shares at $2.44 ($24,364)
  11. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.85 ($28,500)
  12. 4 Open-market buy President of R&D bought 10,000 shares at $2.53 ($25,250)
  13. 4 Open-market buy Director bought 2,800 shares at an average $2.80 ($7,840)
  14. 3/A Insider 3/A
  15. 3/A Insider 3/A
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Director bought 7,000 shares at $2.80 ($19,600)
  18. 4 Open-market buy Director bought 6,800 shares at $2.79 ($18,971)
  19. 4 Open-market buy Director bought 10,000 shares at $2.81 ($28,050)
  20. 4 Open-market buy Director bought 7,232 shares at $2.74 ($19,816)

Page 13 of 21 · 420 filings